| Primary |
| Hypertonic Bladder |
67.4% |
| Urinary Incontinence |
10.6% |
| Pollakiuria |
8.5% |
| Hypertension |
1.9% |
| Micturition Urgency |
1.7% |
| Urge Incontinence |
1.5% |
| Incontinence |
1.3% |
| Depression |
1.0% |
| Cystitis |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
| Bladder Disorder |
0.7% |
| Bladder Spasm |
0.5% |
| Diabetes Mellitus |
0.5% |
| Nocturia |
0.4% |
| Convulsion |
0.4% |
| Blood Pressure Management |
0.3% |
| Urinary Retention |
0.3% |
| Urinary Tract Infection |
0.3% |
| Blood Cholesterol Increased |
0.2% |
| Dyspepsia |
0.2% |
|
| Drug Ineffective |
27.8% |
| Dry Mouth |
16.3% |
| Pollakiuria |
9.7% |
| Constipation |
8.2% |
| Vision Blurred |
6.2% |
| Urinary Incontinence |
3.4% |
| Urinary Retention |
3.2% |
| Somnolence |
2.7% |
| Nausea |
2.6% |
| Rash |
2.5% |
| Headache |
2.4% |
| Dyspepsia |
2.2% |
| Dizziness |
2.1% |
| Stomach Discomfort |
1.9% |
| Oedema Peripheral |
1.7% |
| Insomnia |
1.6% |
| Pruritus |
1.6% |
| Nocturia |
1.3% |
| Vomiting |
1.3% |
| Diarrhoea |
1.1% |
|
| Secondary |
| Urinary Incontinence |
20.2% |
| Hypertonic Bladder |
19.7% |
| Pollakiuria |
7.3% |
| Incontinence |
6.2% |
| Urge Incontinence |
6.2% |
| Drug Use For Unknown Indication |
5.1% |
| Bladder Disorder |
3.9% |
| Blood Pressure Management |
3.9% |
| Hypertension |
3.9% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Cystitis |
2.2% |
| Gallbladder Non-functioning |
2.2% |
| Hypersensitivity |
2.2% |
| Micturition Urgency |
2.2% |
| Postnasal Drip |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Prostatomegaly |
2.2% |
| Bipolar Disorder |
1.7% |
| Depression |
1.7% |
| Diabetes Mellitus |
1.7% |
|
| Vision Blurred |
10.3% |
| Drug Ineffective |
9.0% |
| Weight Decreased |
9.0% |
| Dry Mouth |
6.4% |
| Hypotension |
6.4% |
| Constipation |
5.1% |
| Paraesthesia Oral |
5.1% |
| Pollakiuria |
5.1% |
| Stool Analysis Abnormal |
5.1% |
| Vaginal Haemorrhage |
5.1% |
| Wean From Ventilator |
5.1% |
| Pulmonary Embolism |
3.8% |
| Urinary Incontinence |
3.8% |
| Urticaria |
3.8% |
| Visual Disturbance |
3.8% |
| Death |
2.6% |
| Dysuria |
2.6% |
| Fatigue |
2.6% |
| Gastrointestinal Surgery |
2.6% |
| Malaise |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.6% |
| Drug Use For Unknown Indication |
19.0% |
| Multiple Sclerosis |
7.8% |
| Hypertension |
5.9% |
| Pain |
5.6% |
| Gastrooesophageal Reflux Disease |
4.0% |
| Depression |
3.7% |
| Rheumatoid Arthritis |
3.0% |
| Osteoporosis |
2.8% |
| Urinary Incontinence |
2.8% |
| Diabetes Mellitus |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Supplementation Therapy |
2.3% |
| Bladder Disorder |
2.2% |
| Anxiety |
2.2% |
| Migraine |
2.2% |
| Blood Cholesterol Increased |
2.0% |
| Hypertonic Bladder |
1.9% |
| Insomnia |
1.7% |
| Bipolar Disorder |
1.5% |
|
| Urinary Tract Infection |
12.9% |
| Weight Decreased |
10.4% |
| Vomiting |
9.3% |
| Weight Increased |
8.6% |
| Viral Upper Respiratory Tract Infection |
5.4% |
| Tremor |
5.0% |
| Wrong Technique In Drug Usage Process |
4.6% |
| Pulmonary Embolism |
3.9% |
| Diarrhoea |
3.6% |
| Drug Ineffective |
3.6% |
| Headache |
3.6% |
| Pain In Extremity |
3.6% |
| Type 2 Diabetes Mellitus |
3.6% |
| Upper Respiratory Tract Infection |
3.6% |
| Vision Blurred |
3.6% |
| Death |
3.2% |
| Pneumonia |
3.2% |
| Convulsion |
2.9% |
| Insomnia |
2.9% |
| Product Quality Issue |
2.9% |
|
| Interacting |
| Erectile Dysfunction |
66.7% |
| Incontinence |
33.3% |
|
| Stomach Discomfort |
100.0% |
|
